Clinical Trials Browser

Phase 2 × Leukemia, Promyelocytic, Acute × Ascorbic Acid × Clear all

NCT03624270 2022-10-04

Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Promyelocytic, Acute